DE69018482D1 - Trennungsverfahren zum trennen von hämatopoeitischen vorläuferzellen. - Google Patents

Trennungsverfahren zum trennen von hämatopoeitischen vorläuferzellen.

Info

Publication number
DE69018482D1
DE69018482D1 DE69018482T DE69018482T DE69018482D1 DE 69018482 D1 DE69018482 D1 DE 69018482D1 DE 69018482 T DE69018482 T DE 69018482T DE 69018482 T DE69018482 T DE 69018482T DE 69018482 D1 DE69018482 D1 DE 69018482D1
Authority
DE
Germany
Prior art keywords
cells
hpc
magnetic particles
treated
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69018482T
Other languages
English (en)
Other versions
DE69018482T2 (de
Inventor
Steinar Funderud
Erland Smeland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies AS
Original Assignee
Dynal AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dynal AS filed Critical Dynal AS
Publication of DE69018482D1 publication Critical patent/DE69018482D1/de
Application granted granted Critical
Publication of DE69018482T2 publication Critical patent/DE69018482T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3061Blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Networks Using Active Elements (AREA)
  • Static Random-Access Memory (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69018482T 1989-12-29 1990-12-28 Trennungsverfahren zum trennen von hämatopoeitischen vorläuferzellen. Expired - Fee Related DE69018482T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898929297A GB8929297D0 (en) 1989-12-29 1989-12-29 Method of separation
PCT/EP1990/002327 WO1991009938A1 (en) 1989-12-29 1990-12-28 Method of separating haemopoietic progenitor cells

Publications (2)

Publication Number Publication Date
DE69018482D1 true DE69018482D1 (de) 1995-05-11
DE69018482T2 DE69018482T2 (de) 1995-08-31

Family

ID=10668564

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69018482T Expired - Fee Related DE69018482T2 (de) 1989-12-29 1990-12-28 Trennungsverfahren zum trennen von hämatopoeitischen vorläuferzellen.

Country Status (8)

Country Link
EP (1) EP0507839B1 (de)
JP (1) JPH05504059A (de)
AT (1) ATE120796T1 (de)
CA (1) CA2072563A1 (de)
DE (1) DE69018482T2 (de)
DK (1) DK0507839T3 (de)
GB (1) GB8929297D0 (de)
WO (1) WO1991009938A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007966D0 (en) * 1990-04-09 1990-06-06 Dynal As Antigen/anti-antigen cleavage
US5541072A (en) * 1994-04-18 1996-07-30 Immunivest Corporation Method for magnetic separation featuring magnetic particles in a multi-phase system
US5795470A (en) * 1991-03-25 1998-08-18 Immunivest Corporation Magnetic separation apparatus
GB9125623D0 (en) * 1991-12-02 1992-01-29 Dynal As Cell modification
AU2593192A (en) 1992-09-14 1994-04-12 Oystein Fodstad Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
NO180658C (no) * 1994-03-10 1997-05-21 Oeystein Fodstad Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
ATE340254T1 (de) * 1995-04-06 2006-10-15 Miltenyi Biotec Inc Verfahren zur freisetzung von magnetischen teilchen, die an zelloberflächen gebunden sind
NO961031D0 (no) 1996-03-13 1996-03-13 Det Norske Radiumshospital Tum Fremgangsmåte til å drepe uönskede målceller
JP3863373B2 (ja) * 1999-03-02 2006-12-27 クオリジエン・インコーポレイテツド 生物学的流体の分離のための装置を用いる方法
CN114908033A (zh) * 2022-04-18 2022-08-16 广东莱迪生物医药研究院有限公司 一种大批量磁珠分选细胞的方法

Also Published As

Publication number Publication date
GB8929297D0 (en) 1990-02-28
WO1991009938A1 (en) 1991-07-11
ATE120796T1 (de) 1995-04-15
CA2072563A1 (en) 1991-06-30
AU646011B2 (en) 1994-02-03
AU7069791A (en) 1991-07-24
EP0507839B1 (de) 1995-04-05
DK0507839T3 (da) 1995-06-19
DE69018482T2 (de) 1995-08-31
EP0507839A1 (de) 1992-10-14
JPH05504059A (ja) 1993-07-01

Similar Documents

Publication Publication Date Title
Fathman et al. Ia alloantigen (s) detected on thymocytes by use of a fluorescence-activated cell sorter
ES8706964A1 (es) Un procedimiento para fraccionar anticuerpos de suero.
NO931747D0 (no) Fremgangsmaate ved undersoekelse av glycerte blodproteiner,samt anordning for utfoerelse av fremgangsmaaten
MX162170A (es) Mejoras en clasificador de monedas
NO913186L (no) Fremgangsmaate for anvendelse og syntese av peptider.
GR3036951T3 (en) Cells with multiple altered epitopes on a surface antigen for use in transplantation
DE69018482T2 (de) Trennungsverfahren zum trennen von hämatopoeitischen vorläuferzellen.
DE69115267D1 (de) Antigen-/antiantigenspaltung.
JPS5637009A (en) Selective separating method for protein substance
FI932912A0 (fi) Testmetod och reagensfoerpackning avsedd foer den
AU525403B2 (en) Purified antigen
FR2708348B1 (fr) Procédé de dosage d'une substance immunologique au moyen de particules de latex magnétiques et de particules non-magnétiques.
DE3376360D1 (en) Fucosyl antigens, a process for their preparation and antibodies for recognising them, a cancer diagnosing kit containing the fucosyl antigens and a method for determination of cancer associated carbohydrate linkages
IL70746A0 (en) Specific cea-family antigens,antibodies specific thereto and methods for the use thereof
EP0109434A4 (de) In vitro diagnoseverfahren unter verwendung von monoklonalen antikörpern gegen konnektive gewebeproteine.
KR900700131A (ko) 유사분열물질에 의한 면역자극 혈액처리를 위한 방법 및 장치
DE3751331T2 (de) Nachweisverfahren eines zellenoberflächenantigens.
IE792390L (en) Hepatitis be antigen.
Dorval et al. Analysis of cell-surface markers with staphylococcal protein A: Fluorescence studies on mammalian lymphoid determinants
SE8803208D0 (sv) In vitro immunisering av lymfocytinnehallande cellpopulationer och materialsats derfor
WO1979000675A1 (en) Improvement in viral hemoagglutination inhibition test
Zöller et al. Specific cytotoxicity in vitro by T-cell-enriched lymphocyte subpopulations from rats bearing chemically induced but not spontaneous tumors
Sandeman et al. Characterization of sheep antibodies involved in precipitate formation with surface antigens of Fasciola hepatica in vitro
SU668684A1 (ru) Способ приготовлени стандартных универсальных антирезус-сывороток
Egorova et al. Characteristics of cytotoxic T lymphocytes eluted from allogeneic target cells

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee